A detailed history of Twin Capital Management Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Twin Capital Management Inc holds 20,590 shares of BSX stock, worth $1.86 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
20,590
Previous 20,726 0.66%
Holding current value
$1.86 Million
Previous $1.6 Million 8.08%
% of portfolio
0.2%
Previous 0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$72.96 - $84.0 $9,922 - $11,424
-136 Reduced 0.66%
20,590 $1.73 Million
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $14,408 - $16,629
214 Added 1.04%
20,726 $1.6 Million
Q1 2024

May 13, 2024

SELL
$57.6 - $68.62 $143,078 - $170,452
-2,484 Reduced 10.8%
20,512 $1.4 Million
Q4 2023

Jan 31, 2024

BUY
$48.64 - $57.81 $88,330 - $104,982
1,816 Added 8.57%
22,996 $1.33 Million
Q3 2023

Nov 13, 2023

BUY
$50.19 - $54.68 $1.06 Million - $1.16 Million
21,180 New
21,180 $1.12 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Twin Capital Management Inc Portfolio

Follow Twin Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.